Vicapsys Life Sciences annual net income
2019
2020
2021
2022
2023
Vicapsys Life Sciences Net Income Growth & History (VICP)
Vicapsys Life Sciences's net income was −$1.2M for fiscal 2023.
View full Vicapsys Life Sciences company overviewVicapsys Life Sciences annual net income history
| Fiscal year | Period ended | Net income | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | −$1.2M | −$197,322 | — |
| 2022 | 2022-12-31 | −$984,790 | −$747,919 | — |
| 2021 | 2021-12-31 | −$236,871 | $528,973 | — |
| 2020 | 2020-12-31 | −$765,844 | $643,852 | — |
| 2019 | 2019-12-31 | −$1.4M | — | — |
Vicapsys Life Sciences quarterly net income
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
| Fiscal quarter | Period ended | Net income | Change | YoY change |
|---|---|---|---|---|
| Q3 2024 | 2024-09-30 | −$235,507 | $4,833 | — |
| Q2 2024 | 2024-06-30 | −$190,091 | −$54,398 | — |
| Q1 2024 | 2024-03-31 | −$327,072 | −$115,795 | — |
| Q4 2023 | 2023-12-31 | −$594,802 | −$102,196 | — |
| Q3 2023 | 2023-09-30 | −$240,340 | −$95,259 | — |
| Q2 2023 | 2023-06-30 | −$135,693 | $44,363 | — |
| Q1 2023 | 2023-03-31 | −$211,277 | −$44,230 | — |
| Q4 2022 | 2022-12-31 | −$492,606 | −$388,748 | — |
| Q3 2022 | 2022-09-30 | −$145,081 | −$33,900 | — |
| Q2 2022 | 2022-06-30 | −$180,056 | −$107,994 | — |
| Q1 2022 | 2022-03-31 | −$167,047 | −$217,277 | — |
| Q4 2021 | 2021-12-31 | −$103,858 | −$23,309 | — |
| Q3 2021 | 2021-09-30 | −$111,181 | −$21,960 | — |
| Q2 2021 | 2021-06-30 | −$72,062 | $159,553 | — |
| Q1 2021 | 2021-03-31 | $50,230 | $414,689 | — |
| Q4 2020 | 2020-12-31 | −$80,549 | $169,083 | — |
| Q3 2020 | 2020-09-30 | −$89,221 | $380,119 | — |
| Q2 2020 | 2020-06-30 | −$231,615 | $16,452 | — |
| Q1 2020 | 2020-03-31 | −$364,459 | $78,198 | — |
| Q4 2019 | 2019-12-31 | −$249,632 | — | — |
| Q3 2019 | 2019-09-30 | −$469,340 | — | — |
| Q2 2019 | 2019-06-30 | −$248,067 | — | — |
| Q1 2019 | 2019-03-31 | −$442,657 | — | — |
Vicapsys Life Sciences net income trends
Between the periods ended 2019-12-31 and 2023-12-31, Vicapsys Life Sciences's net income increased from −$1.4M to −$1.2M, a change of $227,584. The latest reported quarter, Q3 2024, shows −$235,507.
About the metric
What net income means
Net income is a company’s bottom-line profit or loss after operating costs, interest, taxes, and other reported income and expenses. It shows how much of a company’s revenue ultimately remained as earnings, or how large its loss was, during a fiscal period.
Calculation and source
SEC-reported net income
TickerStat standardizes consolidated net income or profit and loss reported in company SEC filings for aligned fiscal periods. It is not adjusted earnings, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vicapsys Life Sciences source filings ↗